The Dynamic Assessment and Referral System for Substance Abuse (DARSSA): development, functionality, and end-user satisfaction
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Boudreaux, Edwin D.Bedek, Kristyna L.
Gilles, Donna
Baumann, Brigitte M.
Hollenberg, Steven
Lord, Sherrill A.
Grissom, Grant
UMass Chan Affiliations
Department of Emergency MedicineDocument Type
Accepted ManuscriptPublication Date
2009-01-09Keywords
Data Interpretation, StatisticalFollow-Up Studies
Humans
New Jersey
Patient Satisfaction
Patient Selection
Population
*Referral and Consultation
Self-Assessment
*Software
Substance Abuse Treatment Centers
Substance-Related Disorders
Telephone
Treatment Outcome
technology
substance abuse treatment
referrals
treatment matching
substance abuse screening
treatment initiation
Emergency Medicine
Health Information Technology
Health Services Administration
Health Services Research
Substance Abuse and Addiction
Therapeutics
Metadata
Show full item recordAbstract
The Dynamic Assessment and Referral System for Substance Abuse (DARSSA) conducts a computerized substance abuse assessment; prints personalized summary reports that include tailored substance abuse treatment referral lists; and, for individuals who provide authorization, automatically faxes their contact information to a "best match" substance abuse treatment provider (dynamic referral). After piloting the program and resolving problems that were noted, we enrolled a sample of 85 medical patients. The DARSSA identified 48 (56%) participants who were risky substance users, many of whom had not been identified during their routine medical assessment. Mean satisfaction scores for all domains ranged between "Good" to "Excellent" across patients, nurses, doctors, and substance abuse treatment providers. The median completion time was 13min. Of the 48 risky substance using participants, 20 (42%) chose to receive a dynamic referral. The DARSSA provides a user-friendly, desirable service for patients and providers. It has the potential to improve identification of substance abuse in medical settings and to provide referrals that would not routinely be provided. Future studies are planned to establish its efficacy at promoting treatment initiation and abstinence.Source
Drug Alcohol Depend. 2009 Jan 1;99(1-3):37-46. Epub 2008 Sep 4. Link to article on publisher's site
DOI
10.1016/j.drugalcdep.2008.06.015Permanent Link to this Item
http://hdl.handle.net/20.500.14038/28423PubMed ID
18775606Notes
At the time of publication, Edwin Boudreaux was not yet affiliated with the University of Massachusetts Medical School. This is the author’s version of a work that was accepted for publication in Drug and Alcohol Dependence. A definitive version was subsequently published in Drug Alcohol Depend. 2009 Jan 1;99(1-3):37-46. DOI 10.1016/j.drugalcdep.2008.06.015
Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.drugalcdep.2008.06.015
Scopus Count
Related items
Showing items related by title, author, creator and subject.
-
Substance Use Disorder Treatment in the Time of COVIDShanahan, Christopher W; Halpin, Susan M. (2021-01-28)Primary care clinicians face many challenges when addressing the complex needs of patients with chronic pain, substance use disorders or both. Over the last 10 months, the SARS-CoVID-2 pandemic has both increased and changed the challenges that healthcare providers face. Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) is a free service that helps doctors and other clinicians meet these challenges by increasing their capacity for, and comfort in, using evidence-based practices to screen, diagnose, treat and manage the care of these patients. MCSTAP provides on-demand physician consultation on safe prescribing and managing the care of patients with chronic pain and/or SUD. Join us for a webinar to learn about the innovative services that MCSTAP provides. Christopher Shanahan MD MPH FACP will share his knowledge about why and experience about how MCSTAP was created. You will learn about how SARS-CoVID-2 pandemic has changed SUD treatment and prescribing protocols. Currently, the SARS-CoVID-2 pandemic has presented serious and life-threatening challenges to both patients and to their clinicians. After attending this webinar, participants will: Understand the bidirectional relationship of SARS-Cov-2 pandemic & the epidemic U.S. Substance Use on identification & treatment of physical, mental health & Substance Use Disorders (SUD) e.g. opioid crisis Describe components & impact of Social Determinants of Health (SDOH) on care of individuals with SUD & impact on the risk for & clinical outcomes of SARS-CoV-2 infection Employ Intersectionality to identify/analyze key areas of need & potential for high impact & then develop/implement evidence-based & innovative solutions.
-
Community referral sources and entry of treatment-naive clients into outpatient addiction treatmentFriendmann, Peter D.; Lemon, Stephenie C.; Stein, Michael D.; D'Aunno, Thomas A. (2003-05-07)This study assessed the association of sources of client referral with enrollment of treatment-naive clients. Data from the 1995 (n = 618) and 2000 (n = 745) waves of the National Drug Abuse Treatment Survey (DATSS), a panel study of outpatient substance abuse treatment units (OSAT), were analyzed. Enrollment of treatment-naive clients was defined as the percentage of OSAT clients who entered treatment in the past 30 days with no prior treatment for substance abuse. A generalized estimating equation model simultaneously assessed the association of each referral source with the dependent variable, while controlling for potential confounding and accounting for correlation of unit-level responses over time. In the multivariable model, OSAT units with a greater proportion of treatment-naive clients had received more referrals from employee assistance programs and the criminal justice system, and fewer referrals from mental health agencies. No effect of referral from medical or social service agencies was observed. These results highlight the role of coercive community institutions in treatment outreach efforts to persons in earlier phases of the "addiction career."
-
Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey's experienceFoulds, Jonathan; Williams, Jill M.; Order-Connors, Bernice; Edwards, Nancy; Dwyer, Martha; Kline, Anna; Ziedonis, Douglas M. (2007-03-22)New Jersey was the first State to require that all residential addiction treatment programs assess and treat patients for tobacco dependence and maintain tobacco-free facilities (including grounds). An evaluation of this policy change found that tobacco dependence treatment can be successfully integrated into residential substance abuse treatment programs through policy regulation, training, and the provision of nicotine replacement therapy (NRT) (Williams et al. 2005). Many other addiction treatment agencies (both residential and outpatient) around the country now have implemented or are planning to implement similar policies to ensure that their patients receive appropriate assessment and treatment of their tobacco dependence while receiving treatment for addiction to other substances. This paper aims to summarize the lessons learned from the experience in New Jersey.